Neuberger Berman Group
AGN.PRA

Neuberger Berman Group’s Allergan plc AGN.PRA Stock Holding History

Neuberger Berman Group’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,747
Closed -$3.96M – 1816
2017
Q4 		$3.96M Sell
6,747
-52,115
-89% -$33.6M ﹤0.01% 908
2017
Q3 		$43.4M Sell
58,862
-592
-1% -$491K 0.05% 428
2017
Q2 		$51.6M Sell
59,454
-9,603
-14% -$8.05M 0.07% 380
2017
Q1 		$58.6M Buy
69,057
+34,759
+101% +$28.8M 0.08% 355
2016
Q4 		$26.2M Sell
34,298
-22,689
-40% -$17.1M 0.04% 522
2016
Q3 		$46.8M Buy
56,987
+23,129
+68% +$20M 0.06% 390
2016
Q2 		$28.2M Buy
33,858
+4,151
+14% +$3.47M 0.04% 506
2016
Q1 		$27.3M Sell
29,707
-3,220
-10% -$3.08M 0.04% 506
2015
Q4 		$33.9M Sell
32,927
-3,135
-9% -$3.15M 0.04% 472
2015
Q3 		$34M Buy
36,062
+86
+0.2% +$89.7K 0.04% 479
2015
Q2 		$37.6M Buy
+35,976
New +$37.7M 0.04% 501

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Neuberger Berman Group's AGN.PRA Position: Q1 2018 in Review

Neuberger Berman Group sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 6,747 shares — an estimated $3.96M sold.

Neuberger Berman Group first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $58.6M in Q1 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Neuberger Berman Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Neuberger Berman Group sold 6,747 Allergan plc shares in Q1 2018, an estimated $3.96M.
  • Neuberger Berman Group first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Neuberger Berman Group's Allergan plc position peaked at $58.6M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.